Skip to main content
Log in

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

There is a perception that tamoxifen causes weightgain in breast cancer patients. The purpose ofthis research study was to determine if weightgain is associated with tamoxifen therapy and toobserve the impact of weight gain on recurrenceand survival. Prognostic indicators, changes in weight, anddisease status from diagnosis to the end oftreatment were studied in 200 consecutive Stage Iand II breast cancer patients, not receiving systemicchemotherapy, admitted from 1986 to the present, withobservation periods ranging from 3–5 years. A meanweight gain of 1.2 Kgs was seen inall patients; however, weight gain was not significantlydifferent for those receiving tamoxifen vs. those notreceiving tamoxifen, (P=0.66, CI 95% forthe difference –1.8 Kgs to +1.2 Kgs). Weightgain during treatment with tamoxifen was not correlatedwith treatment duration or with recurrence or survival.Age at diagnosis was positively correlated to weightgain in all groups. Our data failed toshow that tamoxifen is associated with weight gain.The moderate weight gain observed in this patientpopulation is comparable to the general aging disease-freepopulation and may not be treatment-related. These findingsmay help to alleviate some concerns of bothphysicians and patients when tamoxifen is the drugof choice for adjuvant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Cancer Society Inc.: Cancer Facts & Figures (ACS Publication no. 5008.95). Atlanta, GA, 1995

  2. Dixon J, Moritz DA, Baker FL: Breast cancer and weight gain: An unexpected finding. Oncology Nursing Forum 5: 5–7, 1978

    Google Scholar 

  3. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH: Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8: 1327–1334, 1990

    Google Scholar 

  4. Demark-Wahnefried W, Winer EP, Rimer BK: Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11: 1418–1429, 1993

    Google Scholar 

  5. Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR: Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7: 23–29, 1986

    Google Scholar 

  6. Levine EG, Racqynski JM, Carpenter JT: Weight gain with breast cancer adjuvant treatment. Cancer 67: 1954–1959, 1991

    Google Scholar 

  7. Goodwin PJ, Panzarella T, Boyd NF: Weight gain in women with localized breast cancer — a descriptive study. Breast Cancer Res Treat 11: 59–66, 1988

    Google Scholar 

  8. Ballard-Barbash R: Anthropometry and breast cancer. Body size — a moving target. Cancer 74:Suppl 1090–1100, 1994

    Google Scholar 

  9. Gray R: Tamoxifen: How boldly to go where no women have gone before. J Nat Cancer Inst 85: 1358–1360, 1993

    Google Scholar 

  10. Chlebowski RT, Butler J, Nelson A, Lillingto L: Breast cancer chemoprevention. Cancer 72: 1032–1037, 1993

    Google Scholar 

  11. Powles TJ: The case for clinical trials of tamoxifen for prevention of breast cancer. The Lancet 340: 1145–1147, 1992

    Google Scholar 

  12. Hoskin PJ, Ashley S, Yarnold JR: Weight gain after primary surgery for breast cancer. Breast Cancer Res Treat 22: 129–132, 1992

    Google Scholar 

  13. Rose DP, Connolly JM, Chlebowski RT, Buzzard IM, Wynder EL: The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of post-menopausal breast cancer patients. Breast Cancer Res Treat 27: 253–262, 1993

    Google Scholar 

  14. Wade GN, Gray JM, Blaustein JD: Effects of estrogens and antiestrogens on eating behavior, metabolism and energy balance. Oncology 7: 61–68, 1993

    Google Scholar 

  15. DeConti R: Weight gain in the adjuvant chemotherapy of breast cancer. Proc ASCO: C-143, 1981 (Abstr)

  16. Donegan WL, Hartz AJ, Rimm AA: The association of body weight and recurrent cancer of the breast. Cancer 41: 1590–1594, 1978

    Google Scholar 

  17. Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW: Body weight and prognosis in breast cancer. J Natl Cancer Inst 67: 785–789, 1981

    Google Scholar 

  18. Tartter PE, Papatestas AE, Iannovitch J, Mulvihill MN, Lesnick G, Aufses AH: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47: 2222–2227, 1981

    Google Scholar 

  19. Zumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holland J, Fukushima DK: Nonobesity at the time of mastectomy is highly predictive of 10 year disease free survival in women with breast cancer. Anticancer Res 2: 59–62, 1982

    Google Scholar 

  20. Ederlein T, Simon R, Fisher S, Lippman ME: Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat 5: 81–86, 1985

    Google Scholar 

  21. Abe R, Kumagai N, Kimura M, Hirosaki A, Nakamura T: Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 120: 351–359, 1976

    Google Scholar 

  22. DeGeorge D, Gray JJ, Fetting JH, Rolls BJ: Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition, and hunger. Oncology Nursing Forum (supp) 17: 23–30, 1990

    Google Scholar 

  23. Schag AC, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L: Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11: 783–793, 1993

    Google Scholar 

  24. O'Brien BJ, Rusthoven J, Rocchi A, Latreille J, Fine S, Vandenberg T, Laberge F: Impact of chemotherapy-associated nausea and vomiting on patients' functional status and costs: Survey of five Canadian centres. Can Med Assoc J 149: 295–304, 1993

    Google Scholar 

  25. Knobf MT: Physical and psychological distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 4: 678–684, 1986

    Google Scholar 

  26. Morrow GR, Asbury R, Hammon S et al.: Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses and clinical psychologists. Health Psychology 11: 250–256, 1992

    Google Scholar 

  27. Cimprich B: A theoretical perspective on attention and patient education. Advances in Nursing Science 14: 39–51, 1992

    Google Scholar 

  28. Nail L, Jones L, Greene D et al.: Use and perceived efficacy of self-care activities in patients receiving chemotherapy. Oncology Nursing Forum 18: 883–887, 1991

    Google Scholar 

  29. Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S: Fatigue and the cancer experience: The state of knowledge. Oncology Nursing Forum 21: 23–26, 1994

    Google Scholar 

  30. Svendsen OL, Hassager C, Christiansen C: Age-and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 44: 369–373, 1995

    Google Scholar 

  31. Wade GN, Gray JM, Blaustein JD: Effects of estrogens and anti-estrogens on eating behavior, metabolism, and energy balance. Cancer 7(suppl): 61–68, 1993

    Google Scholar 

  32. DenBesten C, Vansant G, Westrate JA, Deurenberg P: Resting metabolic rate and diet-induced thermogenesis in abdominal and gluteal-femoral obese women before and after weight reduction. Am J Clin Nutr 47: 840–847, 1988

    Google Scholar 

  33. Poehlman ET, Toth MJ, Gardner AW: Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 123: 673–675, 1995

    Google Scholar 

  34. Haarbo J, Marslew U, Gotfredson A, Christiansen C: Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40: 1323–1326, 1991

    Google Scholar 

  35. Wang Q, Hassager C, Ravn P, Wang S, Christiansen C: Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related? Am J Clin Nutr 60: 843–848, 1994

    Google Scholar 

  36. Wing RR: Obesity and weight gain during adulthood: A health problem for United States women. Women's Health Issues 2: 114–122, 1992

    Google Scholar 

  37. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL: Weight gain at the time of menopause. Arch Int Med 151: 97–103, 1991

    Google Scholar 

  38. Williamson DF, Kahn HS, Patrick RL, Anda RF: The 10-year incidence of overweight and major weight gain in US adults. Arch Int Med 150: 665–672, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, N., Allen, K., Cantor, A. et al. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?. Breast Cancer Res Treat 44, 135–143 (1997). https://doi.org/10.1023/A:1005721720840

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005721720840

Navigation